cyclo(sulfoalanyl-prolyl-valyl-leucyl-tryptophyl) has been researched along with u 44069 in 1 studies
| Studies (cyclo(sulfoalanyl-prolyl-valyl-leucyl-tryptophyl)) | Trials (cyclo(sulfoalanyl-prolyl-valyl-leucyl-tryptophyl)) | Recent Studies (post-2010) (cyclo(sulfoalanyl-prolyl-valyl-leucyl-tryptophyl)) | Studies (u 44069) | Trials (u 44069) | Recent Studies (post-2010) (u 44069) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 108 | 2 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cirino, M; Ford-Hutchinson, AW; Maw, J; Motz, C; Yano, M | 1 |
1 other study(ies) available for cyclo(sulfoalanyl-prolyl-valyl-leucyl-tryptophyl) and u 44069
| Article | Year |
|---|---|
BQ-153, a novel endothelin (ET)A antagonist, attenuates the renal vascular effects of endothelin-1.
Topics: Amino Acid Sequence; Animals; Connective Tissue; Dose-Response Relationship, Drug; Endothelins; Molecular Sequence Data; Peptides, Cyclic; Prostaglandin Endoperoxides, Synthetic; Renal Circulation; SRS-A; Swine | 1992 |